Usefulness of computed tomography to predict residual mitral regurgitation after transcatheter mitral valve edge-to-edge repair

Published:August 10, 2022DOI:


      • Residual mitral regurgitation (MR) after MitraClip impacts long-term outcomes
      • Computed tomography is useful to predict residual MR
      • Mitral valve orifice area/mitral annulus area (MVOA/MAA) ratio and leaflet calcium were predictors of residual MR
      • MVOA/MAA <0.31 and leaflet calcium increased risk of mitral reintervention at 1 year



      Multidetector computed tomography (MDCT) can provide valuable information for preprocedural planning of transcatheter mitral valve interventions. However, no data exist on MDCT parameters predicting residual mitral regurgitation (MR) post-MitraClip (Abbott Laboratories, Abbott Park, IL, USA).


      We analyzed preprocedural MDCTs of 78 consecutive patients with secondary MR undergoing MitraClip implantation at our institution. Moderate-or-severe mitral leaflet calcification (MLC) was defined as calcification, with-or-without mitral annular calcification, extending beyond the mitral leaflet base. Residual MR was assessed by postprocedural transesophageal echocardiography, and clinical outcomes were assessed at 1-year.


      Fifteen patients (19 %) had residual MR ≥2+. Compared to patients with none-or-mild residual MR, MDCT-derived mitral valve orifice area (MVOA) to mitral annulus area (MAA) ratio was significantly lower (0.32 ± 0.06 vs. 0.39 ± 0.09; p = 0.003), and the prevalence of MLC was higher (40 % vs. 18 %; p = 0.057) in those with residual MR ≥2+. Furthermore, the MVOA/MAA ratio and MLC were independent predictors of residual MR ≥2+ post-MitraClip [adjusted odds ratio (ORadj): 0.88 (0.80–0.97) and 5.50 (1.16–26.23), respectively]. On receiver-operating-characteristic-curve analysis, MVOA/MAA ratio <0.31 had a sensitivity of 87 % and a specificity of 60 % for residual MR ≥2+. When patients were classified according to the presence of MLC and an MVOA/MAA ratio <0.31, those with both parameters had significantly higher rates of postprocedural residual MR ≥2+ and mitral reintervention at 1-year than those with only one, and those without both parameters.


      In patients with secondary MR undergoing the MitraClip procedure, preprocedural MDCT parameters, specifically MVOA/MAA ratio and MLC, are useful to predict postprocedural residual MR.

      Graphical abstract


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bonow R.O.
        • O'Gara P.T.
        • Adams D.H.
        • Badhwar V.
        • Bavaria J.E.
        • Elmariah S.
        • et al.
        2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the american College of Cardiology Solution set Oversight Committee.
        J Am Coll Cardiol. 2020; 75: 2236-2270
        • Writing Committee Members
        • Otto C.M.
        • Nishimura R.A.
        • Bonow R.O.
        • Carabello B.A.
        • Erwin III, J.P.
        2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
        J Am Coll Cardiol. 2021; 77 (e25-197)
        • Reichart D.
        • Kalbacher D.
        • Rubsamen N.
        • Tigges E.
        • Thomas C.
        • Schirmer J.
        • et al.
        The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation.
        Eur J Heart Fail. 2020; 22: 1840-1848
        • Feldman T.
        • Foster E.
        • Glower D.D.
        • Kar S.
        • Rinaldi M.J.
        • Fail P.S.
        • et al.
        Percutaneous repair or surgery for mitral regurgitation.
        N Engl J Med. 2011; 364: 1395-1406
        • Stone G.W.
        • Lindenfeld J.
        • Abraham W.T.
        • Kar S.
        • Lim D.S.
        • Mishell J.M.
        • et al.
        Transcatheter mitral-valve repair in patients with heart failure.
        N Engl J Med. 2018; 379: 2307-2318
        • Tabata N.
        • Weber M.
        • Sugiura A.
        • Ozturk C.
        • Ishii M.
        • Tsujita K.
        • et al.
        Impact of the leaflet-to-annulus index on residual mitral regurgitation in patients undergoing edge-to-edge mitral repair.
        JACC Cardiovasc Interv. 2019; 12: 2462-2472
        • Hirasawa K.
        • Namazi F.
        • Milhorini Pio S.
        • Vo N.M.
        • Ajmone Marsan N.
        • Bax J.J.
        • et al.
        Insufficient mitral leaflet remodeling in relation to annular dilation and risk of residual mitral regurgitation after MitraClip implantation.
        JACC Cardiovasc Imaging. 2021; 14: 756-765
        • Blanke P.
        • Dvir D.
        • Cheung A.
        • Levine R.A.
        • Thompson C.
        • Webb J.G.
        • et al.
        Mitral annular evaluation with CT in the context of transcatheter mitral valve replacement.
        JACC Cardiovasc Imaging. 2015; 8: 612-615
        • Yoon S.H.
        • Bleiziffer S.
        • Latib A.
        • Eschenbach L.
        • Ancona M.
        • Vincent F.
        • et al.
        Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement.
        JACC Cardiovasc Interv. 2019; 12: 182-193
        • Zoghbi W.A.
        • Adams D.
        • Bonow R.O.
        • Enriquez-Sarano M.
        • Foster E.
        • Grayburn P.A.
        • et al.
        Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.
        J Am Soc Echocardiogr. 2017; 30: 303-371
        • Bloodworth CHt
        • Pierce E.L.
        • Kohli K.
        • Deaton N.J.
        • Jones K.J.
        • Duvvuri R.
        Impact of simulated MitraClip on forward flow obstruction in the setting of mitral leaflet tethering: an in vitro investigation.
        Catheter Cardiovasc Interv. 2018; 92: 797-807
        • Magne J.
        • Pibarot P.
        • Dagenais F.
        • Hachicha Z.
        • Dumesnil J.G.
        • Senechal M.
        Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation.
        Circulation. 2007; 115: 782-791
        • Eleid M.F.
        • Foley T.A.
        • Said S.M.
        • Pislaru S.V.
        • Rihal C.S.
        Severe mitral annular calcification: multimodality imaging for therapeutic strategies and interventions.
        JACC Cardiovasc Imaging. 2016; 9: 1318-1337
        • Mahnken A.H.
        • Muhlenbruch G.
        • Das M.
        • Wildberger J.E.
        • Kuhl H.P.
        • Gunther R.W.
        • et al.
        MDCT detection of mitral valve calcification: prevalence and clinical relevance compared with echocardiography.
        AJR Am J Roentgenol. 2007; 188: 1264-1269
        • Murphy D.J.
        • Ge Y.
        • Don C.W.
        • Keraliya A.
        • Aghayev A.
        • Morgan R.
        • et al.
        Use of cardiac computerized tomography to predict neo-left ventricular outflow tract obstruction before transcatheter mitral valve replacement.
        J Am Heart Assoc. 2017; 6e007353
        • Yoon S.H.
        • Whisenant B.K.
        • Bleiziffer S.
        • Delgado V.
        • Dhoble A.
        • Schofer N.
        • et al.
        Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.
        Eur Heart J. 2019; 40: 441-451
        • Obadia J.F.
        • Messika-Zeitoun D.
        • Leurent G.
        • Iung B.
        • Bonnet G.
        • Piriou N.
        • et al.
        Percutaneous repair or medical treatment for secondary mitral regurgitation.
        N Engl J Med. 2018; 379: 2297-2306
        • Grayburn P.A.
        New concepts in functional mitral regurgitation: it is not just a disease of the left ventricle.
        J Am Coll Cardiol. 2013; 61: 1817-1819
        • Grande-Allen K.J.
        • Borowski A.G.
        • Troughton R.W.
        • Houghtaling P.L.
        • Dipaola N.R.
        • Moravec C.S.
        • et al.
        Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study.
        J Am Coll Cardiol. 2005; 45: 54-61
        • Puri R.
        • Dundon B.K.
        • Khurana S.
        • Worthley M.I.
        • Edwards J.
        • Worthley S.G.
        Gross echocardiographic underestimation of mitral valve calcification–a near fatal experience.
        Int J Cardiol. 2010; 143 (e24-6)